Diane Meares

Effects of Shear Stress on Production of FVIII and vWF in a Cell-Based Therapeutic for Hemophilia A

A. Atala, A. Skardal, Julio Aleman, 2021, Frontiers in Bioengineering and Biotechnology.

Defining the Optimal FVIII Transgene for Placental Cell-Based Gene Therapy to Treat Hemophilia A

A. Atala, G. Almeida-Porada, C. Porada, 2020, Molecular therapy. Methods & clinical development.

Comparison of different gene addition strategies to modify placental derived-mesenchymal stromal cells to produce FVIII

C. Bishop, C. Langefeld, A. Atala, 2022, Frontiers in Immunology.

Investigating Optimal Autologous Cellular Platforms for Prenatal or Perinatal Factor VIII Delivery to Treat Hemophilia A

C. Rodman, A. Atala, G. Almeida-Porada, 2021, Frontiers in Cell and Developmental Biology.

In Utero Transplantation of FVIII-Expressing Human Placental Cells Upregulates Gene Pathways Associated with Immune Tolerance, Altering the Response to Postnatal FVIII Infusion

A. Atala, C. Porada, H. Spencer, 2021, Blood.

Transplanting FVIII/ET3-secreting cells in fetal sheep increases FVIII levels long-term without inducing immunity or toxicity

A. Atala, D. Schwahn, G. Almeida-Porada, 2023, Nature communications.